<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-35655</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0097992</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biomarkers</subject></subj-group></subj-group><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Infectious disease epidemiology</subject></subj-group></subj-group><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Tuberculosis</subject></subj-group></subj-group></subj-group><subj-group><subject>Pathology and laboratory medicine</subject></subj-group><subj-group><subject>Pediatrics</subject><subj-group><subject>Child health</subject></subj-group></subj-group><subj-group><subject>Public and occupational health</subject><subj-group><subject>Global health</subject></subj-group></subj-group><subj-group><subject>Tropical diseases</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Clinical research design</subject><subject>Cross-sectional studies</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title><italic>Mycobacterium tuberculosis</italic> Infection in Young Children: Analyzing the Performance of the Diagnostic Tests</article-title>
<alt-title alt-title-type="running-head">Tuberculous Infection Diagnostic Tests in Children</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pérez-Porcuna</surname><given-names>Tomàs M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ascaso</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Malheiro</surname><given-names>Adriana</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abellana</surname><given-names>Rosa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martins</surname><given-names>Marilaine</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sardinha</surname><given-names>José Felipe Jardim</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Quincó</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Antunes</surname><given-names>Irineide Assumpção</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>da Silva Garrido</surname><given-names>Marlucia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bührer-Sékula</surname><given-names>Samira</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martinez-Espinosa</surname><given-names>Flor Ernestina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Departament de Salut Pública, Facultat de Medicina, Universitat de Barcelona, Barcelona, Catalunya, Spain</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Servei de Pediatria, CAP Valldoreix, Unitat de Investigació Fundació Mútua Terrassa, Hospital Universitari Mútua Terrassa, Terrassa, Catalunya, Spain</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Catalunya, Spain</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>Laboratório de Imunologia Básica e Aplicada, Fundação de Hematologia e Hemoterapia do Amazonas, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff6"><label>6</label><addr-line>Universidade Federal do Amazonas. Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff7"><label>7</label><addr-line>Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff8"><label>8</label><addr-line>Centro de Referência da Tuberculose, Policlínica Cardoso Fontes, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff9"><label>9</label><addr-line>Programa de Controle da Tuberculose, Departamento de Vigilância Epidemiológica, Fundação de Vigilância em Saúde do Estado do Amazonas, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff10"><label>10</label><addr-line>Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil</addr-line></aff>
<aff id="aff11"><label>11</label><addr-line>Instituto Leônidas e Maria Deane - Fiocruz Amazônia, Fundação Oswaldo Cruz, Manaus, Amazonas, Brazil</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Cardona</surname><given-names>Pere-Joan</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol. Universitat Autònoma de Barcelona. CIBERES, Spain</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">tomas.perez.porcuna@gmail.com</email></corresp>
<fn fn-type="conflict"><p>This work was financially supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq), the Foundation of Research Support of the State of Amazonas (FAPEAM), and the University of Barcelona. Cellestis Ltd. donated QuantiFERON test kits. This does not alter adherence to all PLOS ONE policies on sharing data and materials.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: TPP CA AM SBS FEME. Performed the experiments: TPP AM MM JFJS PQ. Analyzed the data: TPP CA RA. Contributed reagents/materials/analysis tools: TPP CA AM MM JFJS PQ IA MG SBS FEME. Wrote the paper: TPP CA RA. Data interpretation: TPP CA AM RA MM JFJS PQ SBS FEME. Reviewed and revised the manuscript: CA AM RA MM JFJS PQ IA MG SBS FEME.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>30</day><month>5</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>5</issue>
<elocation-id>e97992</elocation-id>
<history>
<date date-type="received"><day>30</day><month>8</month><year>2013</year></date>
<date date-type="accepted"><day>27</day><month>4</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Pérez-Porcuna et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Objective</title>
<p>This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0–6 years) with recent contact with an index tuberculosis case.</p>
</sec><sec>
<title>Materials and Methods</title>
<p>A cross-sectional study including 135 children was conducted in Manaus, Amazonas-Brazil. The TST and QFT were performed and the tests results were analyzed in relation to the personal characteristics of the children studied and their relationship with the index case.</p>
</sec><sec>
<title>Results</title>
<p>The rates of positivity were 34.8% (TST) and 26.7% (QFT), with 14.1% of indeterminations by the QFT. Concordance between tests was fair (Kappa = 0.35 <italic>P</italic>&lt;0.001). Both the TST and QFT were associated with the intensity of exposure (Linear OR = 1.286, <italic>P</italic> = 0.005; Linear OR = 1.161, <italic>P</italic> = 0.035 respectively) with only the TST being associated with the time of exposure (Linear OR = 1.149, <italic>P</italic> = 0.009). The presence of intestinal helminths in the TST+ group was associated with negative QFT results (OR = 0.064, <italic>P</italic> = 0.049). In the TST− group lower levels of ferritin were associated with QFT+ results (Linear OR = 0.956, <italic>P</italic> = 0.036).</p>
</sec><sec>
<title>Conclusions</title>
<p>Concordance between the TST and QFT was lower than expected. The factors associated with the discordant results were intestinal helminths, ferritin levels and exposure time to the index tuberculosis case. In TST+ group, helminths were associated with negative QFT results suggesting impaired cell-mediated immunity. The TST−&amp;QFT+ group had a shorter exposure time and lower ferritin levels, suggesting that QFT is faster and ferritin may be a potential biomarker of early stages of tuberculosis infection.</p>
</sec></abstract>
<funding-group><funding-statement>This work was financially supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq), the Foundation of Research Support of the State of Amazonas (FAPEAM), and the University of Barcelona. Cellestis Ltd. donated QuantiFERON test kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Tuberculosis (TB) is one of the infectious diseases producing the greatest morbidity and mortality worldwide <xref ref-type="bibr" rid="pone.0097992-World1">[1]</xref>. Children represent 5 to 15% of the cases around the world and are more frequently infected and more easily affected and have the most severe forms of the disease <xref ref-type="bibr" rid="pone.0097992-Marais1">[2]</xref>.</p>
<p>Young children are mainly infected in the domiciliary setting by a household-sharing adult patient <xref ref-type="bibr" rid="pone.0097992-Starke1">[3]</xref>. The main strategy of control of TB at a pediatric level is the detection of cases in the study of contacts and early treatment of the infection or disease. Diagnosis of infection is fundamental to implement this strategy <xref ref-type="bibr" rid="pone.0097992-Guidance1">[4]</xref>.</p>
<p>The diagnosis of <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) infection is complex due to the lack of a gold standard <xref ref-type="bibr" rid="pone.0097992-Pai1">[5]</xref>. The study of infection is based on the evaluation of immune response to the exposure of typical antigens of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Pai1">[5]</xref>. For decades the Tuberculin Skin Test (TST) has been the main diagnostic method of <italic>Mtb</italic> infection. It is based on the measurement of cell-mediated immunity expressed through delayed-type hypersensitivity response after subepidermic administration of purified protein derivatives (PPD) of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Comstock1">[6]</xref>. The interpretation of the TST has been questioned especially because of the possibility of false positives in populations with high Calmette-Guérin bacillus vaccine (BCG) coverage and non-tuberculous mycobacteria (NTM) exposure <xref ref-type="bibr" rid="pone.0097992-Farhat1">[7]</xref>. In the last years new diagnostic techniques such as Interferon Gamma Release Assays (IGRAs) have been developed to improve the diagnosis of <italic>Mtb</italic> infection. The IGRAs are based on <italic>in vitro</italic> measurement of interferon gamma (IFN-γ) in the response of T lymphocytes versus the <italic>Mtb</italic>-specific region of difference 1 (RD1) antigens, which are very specific, albeit not exclusive, of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Pai2">[8]</xref>. Numerous studies have been performed to analyze these techniques but relatively few have assessed the performance of these tests in small children <xref ref-type="bibr" rid="pone.0097992-Machingaidze1">[9]</xref>.</p>
<p>The aim of this study was to evaluate the response of the IGRA QuantiFERON-TB Gold In-Tube (QFT) and TST tests in young children with recent exposure to an index case. In addition, we evaluated the factors which may modify test results, with special emphasis on those which alter the immunity of children in a population systematically vaccinated with BCG in the perinatal period.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Ethics Statement</title>
<p>The study was approved by the Ethical Committee in Investigation of the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), October 26, 2007 (Protocol 2865-07). All legal guardians of participants provided written informed consent for inclusion in the study. All the individuals included in the studied received adequate treatment according to their clinical status.</p>
</sec><sec id="s2b">
<title>Setting and Study Population</title>
<p>We conducted a cross-sectional study of comparison of diagnostic tests.</p>
<p>Case recruitment was performed in the Policlínica Cardoso Fontes (regional reference center for TB) and in the FMT-HVD, Manaus, Amazonas, Brazil from March 2009 to February 2010. The adults (greater than 12 years of age) diagnosed with tuberculosis in both centers were questioned about contact with children from 0 to 6 years of age. Those responding affirmatively were invited to bring the children to the center for evaluation and to be invited to participate in the study. All the adult index cases were sputum smear and/or culture positive.</p>
<p>We included children from 0–6 years of age with recent contact with an adult symptomatic TB index case within the last 12 months. Subjects receiving treatment or prophylaxis for TB were excluded. The study was undertaken at an outpatient level.</p>
<p>A sample size of 97 individuals was calculated for the study of concordance between diagnostic tests with a confidence level of 95%, precision of 15%, an expected kappa coefficient of 0.7 and with an expected proportion of positive classified by the diagnostic tests of 35%. These calculations were performed with the EPIDAT 3.1 program (Consellería de Sanidade, Xunta de Galicia, Spain and Pan American Health Organization, Washington D.C., USA).</p>
</sec><sec id="s2c">
<title>Data Collection</title>
<p>Demographic data, epidemiologic history of exposure to an index case of TB, the clinical history of the patient and physical examination were recorded. Chest X-ray, TST, stool and blood analysis (prior to the TST) were performed. The human immunodeficiency virus (HIV) test was not obligatory but was recommended to all the participants.</p>
<p>The <italic>Mycobacterium tuberculosis</italic> contact score (MTC-score) was used to evaluate the intensity of exposure <xref ref-type="bibr" rid="pone.0097992-Hesseling1">[10]</xref>. The MTC-score is from 0 to 15 and is based on the assumption that the gradient of <italic>Mtb</italic> exposure is a composite function of the infectivity of the index case (0–4), the duration of exposure hours per day (0–4), the relationship to the index case (0–4) and the type of exposure (0–3) <xref ref-type="bibr" rid="pone.0097992-Hesseling1">[10]</xref>.</p>
<p>The time (month) from symptom onset to the time of initiation of treatment of the index case was calculated to measure the total exposure time (contagion) of the child to the index case.</p>
<p>Nutritional evaluation: The weight of all the study subjects was obtained and the standard deviation (SD) of the weight was calculated based on age and sex with the Anthro programme (WHO, version 3.2.2, January 2011). The risk of malnutrition was defined as gender-specific weight-for-age less than 1 SD and malnutrition was determined as less than 2 SDs <xref ref-type="bibr" rid="pone.0097992-World2">[11]</xref>.</p>
</sec><sec id="s2d">
<title>Procedures</title>
<p>The TST was performed with an intradermic injection of 2 tuberculin units (TU) of PPD RT23 (Statens Serum Institut, Copenhagen, Denmark) and read 72 hours thereafter. A strong TST reaction (TST+) was defined when induration was ≥10 mm according to the protocols of the World Health Organization (WHO) <xref ref-type="bibr" rid="pone.0097992-Guidance1">[4]</xref>.</p>
</sec><sec id="s2e">
<title>Diagnostic Laboratory Tests</title>
<sec id="s2e1">
<title>Blood tests</title>
<p>The QFT (Cellestis, Carnegie, Australia) was carried out and interpreted according to the manufacturer’s instructions by experienced laboratory technicians who were unaware of the data of the study subjects. The result of the test was considered positive (QFT+) if the net value of IFN-γ to the TB antigens (after subtracting the negative control) was ≥0.35 IU/mL and ≥25% of the value of the negative control, independently of the response of the mitogen. The result of the test was considered negative (QFT−) if the net value of the IFN-γ was &lt;0.35 IU/mL and mitogen response was sufficient (≥0.50 IU/mL). A test result was considered indeterminate if there was excessive IFN-γ production with the negative control tube ≥8.0 IU/mL (indeterminate hypereactive) or with insufficient net mitogen response &lt;0.50 IU/mL plus insufficient net response of the TB antigen &lt;0.35 IU/mL (indeterminate hyporeactive). When the QFT result was indeterminate the test was repeated to confirm the result. Quantitative determination of 25-OH vitamin D and ferritin was made by immunoassay kits (LIAISON 25 OH Vitamin D Total and LIAISON Ferritin, DiaSorin, Saluggia, Italy).</p>
</sec><sec id="s2e2">
<title>Stool collection and examination</title>
<p>Three stool samples were collected from each child on three consecutive days in containers with a wide mouth screw-cap containing 10% formalin. Detection of eggs was made by the spontaneous sedimentation method <xref ref-type="bibr" rid="pone.0097992-Lutz1">[12]</xref>.</p>
</sec></sec><sec id="s2f">
<title>Statistical Analysis</title>
<p>Description of categorical variables was performed using frequency tables, and quantitative variables were determined using medians, means, and interquartile range (IQR). To identify variables associated with the results of the tests bivariate analysis was first performed with the Fisher exact or Chi-square tests for categorical variables, and the Mann Whitney U test was used for quantitative variables followed by multiple logistic regression analysis. The independent variables analyzed were: sex, age, weight by age and sex, corticotherapy or vaccination within the previous 3 months, BCG, passive smoking, characteristics of the index case, characteristics of the child and vitamin D and ferritin levels and the presence of intestinal helminths.</p>
<p>To analyze the discordances between the TST and QFT results multivariate logistic regression was carried out and stratified on the basis of the results of the TST to know the differential behavior of the QFT. Associations between categorical independent variables and the test result are expressed as odds ratio and otherwise as linear odds ratios. The linear odds ratio quantifies the magnitude of the association between the positive response of the test and the change that occurs to a unit increase/decrease in the quantitative variable of interest. To show this effect, a plot of the odds ratio and its confidence interval for each value of levels of the variable was created. The y axis scaled is the same for all the plots.</p>
<p>Concordance between tests was measured using the Kappa index <xref ref-type="bibr" rid="pone.0097992-Landis1">[13]</xref>. The receiver operating characteristic (ROC) curve was used in the TST negative (TST−) group to determine a cut-off of ferritin diagnosis between the QFT positive and negative (QFT+ and QFT−) populations. The type I error was set at 5%. The analyses were performed using the statistical package PASW Statistics 18 (SPSS Inc., Chicago, IL, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Descriptive</title>
<p>We evaluated 140 children for the study of the comparison of the TST and QFT results. Of these, 2 children refused to participate and 3 dropped out and thus, 135 were finally included in the study (<xref ref-type="fig" rid="pone-0097992-g001">Figure 1</xref>).</p>
<fig id="pone-0097992-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.g001</object-id><label>Figure 1</label><caption>
<title>Flow diagram of enrolment (QFT: QuantiFERON-TB Gold In-Tube).</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.g001" position="float" xlink:type="simple"/></fig>
<p>The median age of the participants was 46 months (IQR: 28.0–64.5), with 23.0% being of less than 24 months; 54.8% (74/135) were girls and 90.8% (118/130) presented the BCG scar. Contact with an intrahousehold index TB case occurred in 77.8% (105/135) of the children. The adult source case was smear positive in 45.2% (61/135) and the median MTC-score was 11 (IQR: 6.3–13.0) and the median time of exposure was 1.5 months (IQR: 0.2–3.7). The median ferritin level of the participants was 31.9 ng/mL (IQR: 21.6–45.9). Risk of malnutrition or status of malnutrition was presented by 23.3% (30/129) of the children, intestinal helminths (<italic>Ascaris lumbricoides</italic> and/or <italic>Trichuris trichiura</italic>) were present in 28.6% (30/105) and 33.8% (44/130) were passive smokers (<xref ref-type="table" rid="pone-0097992-t001">Table 1</xref>).</p>
<table-wrap id="pone-0097992-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.t001</object-id><label>Table 1</label><caption>
<title>Baseline demographic and clinical data of the study participants.</title>
</caption><alternatives><graphic id="pone-0097992-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Individuals evaluated</td>
<td align="left" rowspan="1" colspan="1">All Results<xref ref-type="table-fn" rid="nt102">#</xref></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Age (months)</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">46 (28.0; 64.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Less than 24 months</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">31 (23.0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Gender</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">61 (45.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Female</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">74 (54.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BCG scar</bold></td>
<td align="left" rowspan="1" colspan="1">130</td>
<td align="left" rowspan="1" colspan="1">118 (90.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BCG vaccination card</bold></td>
<td align="left" rowspan="1" colspan="1">133</td>
<td align="left" rowspan="1" colspan="1">130 (97.7%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Household contact</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">105 (77.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Adult smear positive</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">61 (45.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Time of exposure (months)</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">1.5 (0.2–3.7)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>MTC-score</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">11 (6.3; 13.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Passive Smokers</bold></td>
<td align="left" rowspan="1" colspan="1">130</td>
<td align="left" rowspan="1" colspan="1">44 (33.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Previous viral infection</bold><xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">28 (20.7%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Previous vaccination (not BCG)</bold><xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">71 (52.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Previous corticoid therapy</bold><xref ref-type="table-fn" rid="nt103">a</xref></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">12 (8.9%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Helminth infection</bold></td>
<td align="left" rowspan="1" colspan="1">105</td>
<td align="left" rowspan="1" colspan="1">30 (28.6%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Z scores forweight-for-age and gender</bold></td>
<td align="left" rowspan="1" colspan="1">129</td>
<td align="left" rowspan="1" colspan="1">−0.13 (−0.9; 0.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Nutrition Status</bold></td>
<td align="left" rowspan="1" colspan="1">129</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Risk of malnutrition<xref ref-type="table-fn" rid="nt104">b</xref></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">19 (14.7%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Malnutrition<xref ref-type="table-fn" rid="nt104">b</xref></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">11 (8.5%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Ferritin level (ng/mL)</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">31.9 (21.6; 45.9)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Vitamin D level (ng/mL)</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">38.1 (24.6; 48.8)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>TST</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Strong reaction (≥10 mm)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">47 (34.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Weak reaction (5–9 mm)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0 (0.0%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No reaction (0–4 mm)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">88 (65.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>QFT result</bold></td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">36 (26.7%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">80 (59.3%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hyperactivity of the negative control</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">10 (7.4%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No reactivity of the positive control</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">9 (6.7%)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: <italic>Mycobacterium tuberculosis</italic> contact score, BCG: Bacillus Calmette-Guérin.</p></fn><fn id="nt102"><label>#</label><p>Categorical variables expressed as number of subjects (n) and percentage (%) compared to those evaluated with the characteristic studied. Quantitative variables expressed as mean and interquartile range (IQR).</p></fn><fn id="nt103"><label>a</label><p>In the 12 weeks prior to the study.</p></fn><fn id="nt104"><label>b</label><p>Risk of malnutrition was defined as a Z score for weight less than −1 SDs for age and gender; malnutrition was defined −2 SDs for age and gender.</p></fn></table-wrap-foot></table-wrap>
<p>The TST showed a strong reaction (≥10 mm) in 34.8% (47/135) of the children, a weak reaction (5–9 mm) in 0% (0/135) and no reaction (0–4 mm) in 65.2% (88/135). The QFT was positive in 26.7% (36/135) of the children, negative in 59.3% (80/135) and indeterminate in 14.1% (19/135) by hyperactivity of the negative control in 7.4% (10/135) [excessive background IFN-γ production] and no reactivity of the positive control in 6.7% (9/135) [insufficient IFN-γ response to mitogen]. Concordance between the TST and QFT (discarding the indeterminate cases) was fair, with a Kappa index of 0.350 (<italic>P</italic>&lt;0.001) (<xref ref-type="table" rid="pone-0097992-t001">Tables 1</xref>, <xref ref-type="table" rid="pone-0097992-t002">2</xref>).</p>
<table-wrap id="pone-0097992-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.t002</object-id><label>Table 2</label><caption>
<title>Comparison of the TST and QFT results.</title>
</caption><alternatives><graphic id="pone-0097992-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="4" align="left" rowspan="1">QFT results</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">Indeterminate</td>
<td align="left" rowspan="1" colspan="1">Indeterminate</td>
<td align="left" rowspan="1" colspan="1">Total</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Hyporeactive</td>
<td align="left" rowspan="1" colspan="1">Hyperreactive</td>
<td align="left" rowspan="1" colspan="1">n (%)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>TST results</bold></td>
<td align="left" rowspan="1" colspan="1">Positive</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">47 (34.8%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Negative</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">88 (65.2%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Total n (%)</td>
<td align="left" rowspan="1" colspan="1">36 (26.7%)</td>
<td align="left" rowspan="1" colspan="1">80 (59.3%)</td>
<td align="left" rowspan="1" colspan="1">9 (6.7%)</td>
<td align="left" rowspan="1" colspan="1">10 (7.4%)</td>
<td align="left" rowspan="1" colspan="1">135 (100.0%)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt105"><label/><p>TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, n: number of subjects.</p></fn></table-wrap-foot></table-wrap>
<p>The samples required to perform the analysis of intestinal helminths were not available in 24.1% of the children. These missing data were not associated with the results of either the TST or the QFT (chi-squared = 1.055 and <italic>P</italic> = 0.788), and the missing data percentages for the four combinations of the test results ranged between 20% and 33%.</p>
</sec><sec id="s3b">
<title>General Concordance and Analysis of the Test Responses</title>
<p>The results of each test were analyzed taking into account the different demographic, epidemiologic and clinical variables of the children included in the study.</p>
<p>Bivariate analysis of the TST+ respect to TST− results showed an association with a greater level of exposure -MTC-score- (U = 796.0 <italic>P</italic>&lt;0.001), greater time of exposure (U = 581.0 <italic>P</italic>&lt;0.001) and with being a passive smoker (chi-square = 5.6 <italic>P</italic> = 0.017). The multivariate logistic regression model indicated that the TST depended on the time of exposure (Linear OR = 1.149; [95% Confidence Interval (CI): 1.036–1.274]) and the MTC-score (Linear OR = 1.286; CI: 1.077–1.536) (<xref ref-type="table" rid="pone-0097992-t003">Table 3</xref> and <xref ref-type="fig" rid="pone-0097992-g002">Figures 2</xref>, <xref ref-type="fig" rid="pone-0097992-g003">3</xref>).</p>
<fig id="pone-0097992-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.g002</object-id><label>Figure 2</label><caption>
<title>Odds ratio and confidence interval of 95% for the Tuberculin Skin Test –TST− (blue) and QuantiFERON-TB Gold in-Tube –QFT− (red) positive results according to the intensity of exposure to index case by <italic>Mycobacterium tuberculosis</italic> contact score (MTC-score).</title>
<p>The MTC-score is from 0 to 15 and is based on the assumption that the gradient of <italic>Mtb</italic> exposure is a composite function of the infectivity of the index case (0–4), the duration of exposure -hours per day- (0–4), the relationship to index case (0–4) and the type of exposure (0–3).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.g002" position="float" xlink:type="simple"/></fig><fig id="pone-0097992-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.g003</object-id><label>Figure 3</label><caption>
<title>Odds ratio and confidence interal of 95% for the Tuberculosis Skin Test positive results according to time of exposure (months) to index case.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.g003" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0097992-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.t003</object-id><label>Table 3</label><caption>
<title>Bivariate analysis and Multivariate logistic regression for TST results and QFT results.</title>
</caption><alternatives><graphic id="pone-0097992-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="5" align="left" rowspan="1">TST results</td>
<td colspan="5" align="left" rowspan="1">QFT results</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Bivariate</td>
<td colspan="2" align="left" rowspan="1">Multivariate</td>
<td colspan="3" align="left" rowspan="1">Bivariate</td>
<td colspan="2" align="left" rowspan="1">Multivariate</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Positive<xref ref-type="table-fn" rid="nt107">#</xref></td>
<td align="left" rowspan="1" colspan="1">Negative<xref ref-type="table-fn" rid="nt107">#</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">Odds Ratio</td>
<td align="left" rowspan="1" colspan="1">Positive<xref ref-type="table-fn" rid="nt107">#</xref></td>
<td align="left" rowspan="1" colspan="1">Negative<xref ref-type="table-fn" rid="nt107">#</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">Odds Ratio</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">N = 39</td>
<td align="left" rowspan="1" colspan="1">N = 77</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(95% CI)</td>
<td align="left" rowspan="1" colspan="1">N = 36</td>
<td align="left" rowspan="1" colspan="1">N = 80</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(95% CI)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age (months)</td>
<td align="left" rowspan="1" colspan="1">45.0</td>
<td align="left" rowspan="1" colspan="1">46.0</td>
<td align="left" rowspan="1" colspan="1">0.863</td>
<td align="left" rowspan="1" colspan="1">0.729</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">47.5</td>
<td align="left" rowspan="1" colspan="1">44.0</td>
<td align="left" rowspan="1" colspan="1">0.241</td>
<td align="left" rowspan="1" colspan="1">0.412</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(26.0, 60.0)</td>
<td align="left" rowspan="1" colspan="1">(24.0, 65.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(32.0, 66.5)</td>
<td align="left" rowspan="1" colspan="1">(23.0, 62.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gender (male)</td>
<td align="left" rowspan="1" colspan="1">46.2%</td>
<td align="left" rowspan="1" colspan="1">40.3%</td>
<td align="left" rowspan="1" colspan="1">0.544</td>
<td align="left" rowspan="1" colspan="1">0.906</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">41.7%</td>
<td align="left" rowspan="1" colspan="1">43.2%</td>
<td align="left" rowspan="1" colspan="1">0.876</td>
<td align="left" rowspan="1" colspan="1">0.665</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BCG scar</td>
<td align="left" rowspan="1" colspan="1">94.9%</td>
<td align="left" rowspan="1" colspan="1">90.5%</td>
<td align="left" rowspan="1" colspan="1">0.418</td>
<td align="left" rowspan="1" colspan="1">0.244</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">97.2%</td>
<td align="left" rowspan="1" colspan="1">89.7%</td>
<td align="left" rowspan="1" colspan="1">0.169</td>
<td align="left" rowspan="1" colspan="1">0.560</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Time of exposure (months)</td>
<td align="left" rowspan="1" colspan="1">4.0</td>
<td align="left" rowspan="1" colspan="1">1.0</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.009</td>
<td align="left" rowspan="1" colspan="1">1.15<xref ref-type="table-fn" rid="nt109">b</xref></td>
<td align="left" rowspan="1" colspan="1">2.0</td>
<td align="left" rowspan="1" colspan="1">1.0</td>
<td align="left" rowspan="1" colspan="1">0.024</td>
<td align="left" rowspan="1" colspan="1">0.537</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(1.0, 10.0)</td>
<td align="left" rowspan="1" colspan="1">(0.0, 3.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(1.04; 1.27)</td>
<td align="left" rowspan="1" colspan="1">(1.0–5.2)</td>
<td align="left" rowspan="1" colspan="1">(0.0–3.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MTC-score</td>
<td align="left" rowspan="1" colspan="1">12.0</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
<td align="left" rowspan="1" colspan="1">1.29<xref ref-type="table-fn" rid="nt109">b</xref></td>
<td align="left" rowspan="1" colspan="1">12.0</td>
<td align="left" rowspan="1" colspan="1">10.0</td>
<td align="left" rowspan="1" colspan="1">0.021</td>
<td align="left" rowspan="1" colspan="1">0.035</td>
<td align="left" rowspan="1" colspan="1">1.16<xref ref-type="table-fn" rid="nt109">b</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(8.2, 14.0)</td>
<td align="left" rowspan="1" colspan="1">(0.0,12,0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(1.08; 1.54)</td>
<td align="left" rowspan="1" colspan="1">(8.0, 14.0)</td>
<td align="left" rowspan="1" colspan="1">(0.0, 12.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(1.01; 1.33)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Passive Smokers</td>
<td align="left" rowspan="1" colspan="1">50.0%</td>
<td align="left" rowspan="1" colspan="1">27.4%</td>
<td align="left" rowspan="1" colspan="1">0.017</td>
<td align="left" rowspan="1" colspan="1">0.323</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">41.7%</td>
<td align="left" rowspan="1" colspan="1">32.9%</td>
<td align="left" rowspan="1" colspan="1">0.365</td>
<td align="left" rowspan="1" colspan="1">0.728</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Previous infection<xref ref-type="table-fn" rid="nt108">a</xref></td>
<td align="left" rowspan="1" colspan="1">15.4%</td>
<td align="left" rowspan="1" colspan="1">26.0%</td>
<td align="left" rowspan="1" colspan="1">0.196</td>
<td align="left" rowspan="1" colspan="1">0.203</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">16.7%</td>
<td align="left" rowspan="1" colspan="1">24.7%</td>
<td align="left" rowspan="1" colspan="1">0.335</td>
<td align="left" rowspan="1" colspan="1">0.836</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Previous vaccination<xref ref-type="table-fn" rid="nt108">a</xref></td>
<td align="left" rowspan="1" colspan="1">59.0%</td>
<td align="left" rowspan="1" colspan="1">49.4%</td>
<td align="left" rowspan="1" colspan="1">0.327</td>
<td align="left" rowspan="1" colspan="1">0.078</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">55.6%</td>
<td align="left" rowspan="1" colspan="1">50.6%</td>
<td align="left" rowspan="1" colspan="1">0.622</td>
<td align="left" rowspan="1" colspan="1">0.631</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Previous corticoid therapy<xref ref-type="table-fn" rid="nt108">a</xref></td>
<td align="left" rowspan="1" colspan="1">15.4%</td>
<td align="left" rowspan="1" colspan="1">6.5%</td>
<td align="left" rowspan="1" colspan="1">0.123</td>
<td align="left" rowspan="1" colspan="1">0.199</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">11.1%</td>
<td align="left" rowspan="1" colspan="1">8.6%</td>
<td align="left" rowspan="1" colspan="1">0.673</td>
<td align="left" rowspan="1" colspan="1">0.801</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Helminth infection</td>
<td align="left" rowspan="1" colspan="1">42.9%</td>
<td align="left" rowspan="1" colspan="1">25.0%</td>
<td align="left" rowspan="1" colspan="1">0.091</td>
<td align="left" rowspan="1" colspan="1">0.252</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">21.4%</td>
<td align="left" rowspan="1" colspan="1">36.1%</td>
<td align="left" rowspan="1" colspan="1">0.167</td>
<td align="left" rowspan="1" colspan="1">0.324</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Z scores for weight-for-age and gender</td>
<td align="left" rowspan="1" colspan="1">−0.1</td>
<td align="left" rowspan="1" colspan="1">−0.3</td>
<td align="left" rowspan="1" colspan="1">0.800</td>
<td align="left" rowspan="1" colspan="1">0.990</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">−0.3</td>
<td align="left" rowspan="1" colspan="1">−0.1</td>
<td align="left" rowspan="1" colspan="1">0.317</td>
<td align="left" rowspan="1" colspan="1">0.858</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(−1.0, 0.3)</td>
<td align="left" rowspan="1" colspan="1">(−0.9, 0.5)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(−1.0, 0.3)</td>
<td align="left" rowspan="1" colspan="1">(−0.9, 0.5)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ferritin level (ng/mL)</td>
<td align="left" rowspan="1" colspan="1">35.2%</td>
<td align="left" rowspan="1" colspan="1">30.6</td>
<td align="left" rowspan="1" colspan="1">0.243</td>
<td align="left" rowspan="1" colspan="1">0.767</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">29.9</td>
<td align="left" rowspan="1" colspan="1">35.4</td>
<td align="left" rowspan="1" colspan="1">0.323</td>
<td align="left" rowspan="1" colspan="1">0.705</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(26.4, 48.4)</td>
<td align="left" rowspan="1" colspan="1">(20.8, 44.7)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(22.3, 40.8)</td>
<td align="left" rowspan="1" colspan="1">(21.6, 49.9)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vitamin D level (ng/mL)</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">35.5</td>
<td align="left" rowspan="1" colspan="1">0.097</td>
<td align="left" rowspan="1" colspan="1">0.963</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">37.7</td>
<td align="left" rowspan="1" colspan="1">35.7</td>
<td align="left" rowspan="1" colspan="1">0.736</td>
<td align="left" rowspan="1" colspan="1">0.227</td>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(26.8, 59.8)</td>
<td align="left" rowspan="1" colspan="1">(23.8, 46.3)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(26.0, 49.1)</td>
<td align="left" rowspan="1" colspan="1">(24.4, 48.9)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt106"><label/><p>TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: <italic>Mycobacterium tuberculosis</italic> contact score, BCG: Bacillus Calmette-Guérin.</p></fn><fn id="nt107"><label>#</label><p>Categorical variables expressed as percentage (%) and quantitative variables expressed as mean and interquartile range (IQR).</p></fn><fn id="nt108"><label>a</label><p>In the 12 weeks prior to the study.</p></fn><fn id="nt109"><label>b</label><p>Linear odds ratio.</p></fn></table-wrap-foot></table-wrap>
<p>On analysis at a bivariate level, QFT+ respect to QFT− results showed an association with the MTC-score (U = 984.0, <italic>P</italic> = 0.021) and time of exposure (U = 894.5 <italic>P = </italic>0.024). The logistic regression model showed that the QFT results only depended on the MTC-score (Linear OR = 1.161; CI: 1.010–1.333) (<xref ref-type="table" rid="pone-0097992-t003">Table 3</xref> and <xref ref-type="fig" rid="pone-0097992-g002">Figure 2</xref>).</p>
</sec><sec id="s3c">
<title>Discordant Study Results</title>
<p>The discordance between the tests was analyzed based on the TST results to identify the possible factors that may explain the QFT results.</p>
<sec id="s3c1">
<title>TST+ patients</title>
<p>In the TST+ patients the presence of greater exposure showed a greater possibility of QFT+ results (Linear OR = 1.727; CI: 1.091–2.735) while the presence of intestinal helminthiasis determined a greater possibility of QFT− results (OR = 0.064; CI: 0.004–0.983) (<xref ref-type="table" rid="pone-0097992-t004">Table 4</xref>).</p>
<table-wrap id="pone-0097992-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.t004</object-id><label>Table 4</label><caption>
<title>Multivariate logistic regression according to factors for positive QFT results stratified by TST results.</title>
</caption><alternatives><graphic id="pone-0097992-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">TST+</td>
<td colspan="3" align="left" rowspan="1">TST−</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">Regression</td>
<td align="left" rowspan="1" colspan="1">Odds Ratio</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">Regression</td>
<td align="left" rowspan="1" colspan="1">Odds Ratio</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Coefficient</td>
<td align="left" rowspan="1" colspan="1">(95% CI)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Coefficient</td>
<td align="left" rowspan="1" colspan="1">(95% CI)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Time of exposure (months)</td>
<td align="left" rowspan="1" colspan="1">0.667</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.593</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MTC-score</td>
<td align="left" rowspan="1" colspan="1">0.020</td>
<td align="left" rowspan="1" colspan="1">0.547<xref ref-type="table-fn" rid="nt111">a</xref></td>
<td align="left" rowspan="1" colspan="1">1.727<xref ref-type="table-fn" rid="nt112">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.288</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(0.234)</td>
<td align="left" rowspan="1" colspan="1">(1.091; 2.735)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Helminth infection</td>
<td align="left" rowspan="1" colspan="1">0.049</td>
<td align="left" rowspan="1" colspan="1">−2.752</td>
<td align="left" rowspan="1" colspan="1">0.064</td>
<td align="left" rowspan="1" colspan="1">0.895</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">-</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(1.395)</td>
<td align="left" rowspan="1" colspan="1">(0.004; 0.983)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ferritin level</td>
<td align="left" rowspan="1" colspan="1">0.143</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.036</td>
<td align="left" rowspan="1" colspan="1">−0.045<xref ref-type="table-fn" rid="nt111">a</xref></td>
<td align="left" rowspan="1" colspan="1">0.956<xref ref-type="table-fn" rid="nt112">b</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(0.021)</td>
<td align="left" rowspan="1" colspan="1">(0.916; 0.997)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt110"><label/><p>TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: <italic>Mycobacterium tuberculosis</italic> contact score, BCG: Bacillus Calmette-Guérin.</p></fn><fn id="nt111"><label>a</label><p>logistic regression coefficient related to quantitative variable.</p></fn><fn id="nt112"><label>b</label><p>Linear odds ratio; exponential to the regression coefficient.</p></fn></table-wrap-foot></table-wrap>
<p>Among the TST+ individuals with intestinal heminths, 66.7% were QFT− (<xref ref-type="table" rid="pone-0097992-t005">Table 5</xref>). However, among those who were TST+ but without helminths only 25.0% were QFT−. On analyzing the concordances between the tests according to the presence of intestinal helminths we found an absence of concordance with the presence of helminths with a Kappa index of 0.211 (<italic>P</italic> = 0.214), showing moderate concordance with a Kappa index of 0.471 (<italic>P</italic>&lt;0.001) when there were no helminths.</p>
<table-wrap id="pone-0097992-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.t005</object-id><label>Table 5</label><caption>
<title>Comparison of the main variables according to TST and QFT results.</title>
</caption><alternatives><graphic id="pone-0097992-t005-5" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.t005" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">MTC-score</td>
<td colspan="2" align="left" rowspan="1">Time of exposure</td>
<td colspan="2" align="left" rowspan="1">Ferritin</td>
<td align="left" rowspan="1" colspan="1">Helminths</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Test results</td>
<td align="left" rowspan="1" colspan="1">N<sub>1</sub></td>
<td align="left" rowspan="1" colspan="1">Median</td>
<td align="left" rowspan="1" colspan="1">IQR</td>
<td align="left" rowspan="1" colspan="1">Median</td>
<td align="left" rowspan="1" colspan="1">IQR</td>
<td align="left" rowspan="1" colspan="1">Median</td>
<td align="left" rowspan="1" colspan="1">IQR</td>
<td align="left" rowspan="1" colspan="1">% (n/N<sub>2</sub>)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">TST+&amp;QFT+</td>
<td align="left" rowspan="1" colspan="1">21</td>
<td align="left" rowspan="1" colspan="1">12.50</td>
<td align="left" rowspan="1" colspan="1">10.25–14.75</td>
<td align="left" rowspan="1" colspan="1">4.00</td>
<td align="left" rowspan="1" colspan="1">1.00–12.00</td>
<td align="left" rowspan="1" colspan="1">34.35</td>
<td align="left" rowspan="1" colspan="1">24.15–65.60</td>
<td align="left" rowspan="1" colspan="1">25.0 (4/16)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TST+&amp;QFT−</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">11.50</td>
<td align="left" rowspan="1" colspan="1">8.00–13.75</td>
<td align="left" rowspan="1" colspan="1">6.71</td>
<td align="left" rowspan="1" colspan="1">1.00–7.50</td>
<td align="left" rowspan="1" colspan="1">35.40</td>
<td align="left" rowspan="1" colspan="1">27.15–41.50</td>
<td align="left" rowspan="1" colspan="1">66.7 (8/12)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TST−&amp;QFT+</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">10.00</td>
<td align="left" rowspan="1" colspan="1">7.00–12.00</td>
<td align="left" rowspan="1" colspan="1">2.00</td>
<td align="left" rowspan="1" colspan="1">1.00–4.00</td>
<td align="left" rowspan="1" colspan="1">26.60</td>
<td align="left" rowspan="1" colspan="1">17.10–31.90</td>
<td align="left" rowspan="1" colspan="1">16.7 (2/12)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TST−&amp;QFT−</td>
<td align="left" rowspan="1" colspan="1">62</td>
<td align="left" rowspan="1" colspan="1">9.50</td>
<td align="left" rowspan="1" colspan="1">0.00–12.00</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">0.00–3.00</td>
<td align="left" rowspan="1" colspan="1">31.00</td>
<td align="left" rowspan="1" colspan="1">21.00–57.70</td>
<td align="left" rowspan="1" colspan="1">27.1 (13/48)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt113"><label/><p>IQR: interquartile range,</p></fn><fn id="nt114"><label/><p>N<sub>1</sub>: number of subjects, TST: Tuberculin Skin Test, QFT: QuantiFERON-TB Gold In-Tube, MTC-score: <italic>Mycobacterium tuberculosis</italic> contact score, n: number of subjects with intestinal helminths;</p></fn><fn id="nt115"><label/><p>N<sub>2</sub>: number of subjects studied for helminths.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c2">
<title>TST− patients</title>
<p>In the TST− patients the QFT results were related to the blood ferritin levels; specifically, the lower the level of ferritin the greater the possibility of being QFT+ (Linear OR = 0.956; CI: 0.916–0.997) (<xref ref-type="table" rid="pone-0097992-t004">Table 4</xref>).</p>
<p>Of the TST− and QFT+ individuals, 86.7% (13/15) showed ferritin levels lower than 31.9 ng/mL (median of all children studied) (<xref ref-type="fig" rid="pone-0097992-g004">Figure 4</xref>). A cut-off point of 37.5 ng/mL was calculated for ferritin with a ROC curve which allowed differentiating the QFT+ from the QFT− individuals in this group, showing a sensitivity of 100% and a specificity of 51%.</p>
<fig id="pone-0097992-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0097992.g004</object-id><label>Figure 4</label><caption>
<title>Box-plot of ferritin levels (ng/mL) according to TST−&amp;QFT+ (n = 15) and TST−&amp;QFT− (n = 62) groups.</title>
<p>Tuberculin Skin Test (TST) and QuantiFERON-TB Gold in-Tube (QFT).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0097992.g004" position="float" xlink:type="simple"/></fig></sec></sec></sec><sec id="s4">
<title>Discussion</title>
<p>The diagnosis of infection by <italic>Mtb</italic> in children is of fundamental importance, especially in regions with a high incidence where BCG vaccination is common. In our study in small children the QFT and TST results were mainly related to the level of exposure to an index case of TB. The discordant results, and thus, the performance of the TST and QFT tests were associated with the presence of intestinal helminths, the length of exposure to an index case and blood ferritin levels.</p>
<p>Although several studies have compared these two diagnostic techniques, the concordances vary widely especially based on the prevalence of TB in the region <xref ref-type="bibr" rid="pone.0097992-Powell1">[14]</xref>. Few studies in young children have evaluated the discordant results between the tests <xref ref-type="bibr" rid="pone.0097992-Machingaidze1">[9]</xref> and the interpretation of the two tests according to the factors associated with the characteristics of contagion and those which may alter immune response.</p>
<sec id="s4a">
<title>General Concordance and Analysis of the Test Responses</title>
<p>In this study the percentage of positives for TST was 34.8%, being 26.7% for QFT, with fair concordance between the two tests (Kappa = 0.35). We observed that the results of both tests were related to the intensity of exposure, although, as previously reported, the TST was more strongly influenced by exposure than QFT <xref ref-type="bibr" rid="pone.0097992-Hesseling1">[10]</xref>, <xref ref-type="bibr" rid="pone.0097992-Dheda1">[15]</xref>. Another factor we observed was that TST+ results were related to a greater time of exposure while the same was not observed for QFT. This finding is fundamental since young children have probably not been previously exposed to <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Comstock1">[6]</xref> thereby suggesting that in our study two different situations may be found, one with short exposure in which we find an early phase of primary infection by <italic>Mtb</italic> and another with a longer time of exposure showing latent tuberculosis infection (LTBI) secondary to primary infection. This may explain the behavior of the different tests according to the time of exposure <xref ref-type="bibr" rid="pone.0097992-Hill1">[16]</xref> due to different immune response in relation to the time of infection observed.</p>
<p>Likewise, we did not observe any association between the TST results and age or the presence of a BCG scar. Thus, previous BCG vaccination or environmental exposure to NTM (in which the probability of weak or strong TST reactions should increase with age due to the greater probability of exposure to NTM) does not, <italic>a priori,</italic> seem to play an important role in TST behavior, similar to what other authors have reported <xref ref-type="bibr" rid="pone.0097992-Almeida1">[17]</xref>, <xref ref-type="bibr" rid="pone.0097992-Raharimanga1">[18]</xref>, especially in tropical regions <xref ref-type="bibr" rid="pone.0097992-Hill2">[19]</xref>. In addition, on analyzing our data the higher rate of TST+ results could be explained; at least in part, by a greater sensitivity or stability over time <xref ref-type="bibr" rid="pone.0097992-Shanaube1">[20]</xref> versus the QFT which may be affected by reversion phenomenon (negativization of the test after positivity) during latent infection <xref ref-type="bibr" rid="pone.0097992-Pai3">[21]</xref>.</p>
</sec><sec id="s4b">
<title>Discordant Test Results</title>
<p>On analyzing the discordant test results in our study the TST+ group was found to have a greater probability of presenting QFT− results in association with the presence of intestinal helminths. Intestinal helminths may explain up to two thirds of the discordant test results in this group, probably due to an ineffective Th1 immune response leading to a lower secretion of IFN-γ <xref ref-type="bibr" rid="pone.0097992-Resende1">[22]</xref> and, thus, a false negativization of the QFT. On quantitative analysis of the values of IFN-γ in the individuals of this group we observed all presented values lower than 0.18 IU/mL. Thus, a lower threshold of positivity for QFT in this population, as suggested by some authors <xref ref-type="bibr" rid="pone.0097992-Pai4">[23]</xref>, <xref ref-type="bibr" rid="pone.0097992-Mandalakas1">[24]</xref>, would not explain the discordant results in this group. To our knowledge the association of intestinal helminths and QFT− results has not been previously described. The involvement of the presence of helminths on QFT performance has been previously reported, being associated with a greater percentage of indeterminate results secondary to no reactivity of the mitogen control <xref ref-type="bibr" rid="pone.0097992-Thomas1">[25]</xref>, <xref ref-type="bibr" rid="pone.0097992-Banfield1">[26]</xref>. This phenomenon may be explained by the immunomodulating capacity of infection by intestinal helminths, producing a strong Th2 immune response and thus, significant suppression of Th1 response <xref ref-type="bibr" rid="pone.0097992-Resende1">[22]</xref>. Human and animal studies have shown that individuals with TB and helminthiasis have a reduction in IFN-γ secretion and the number of T CD4 lymphocytes compared to subjects with TB alone <xref ref-type="bibr" rid="pone.0097992-Resende1">[22]</xref>. Effective immune response to <italic>Mtb</italic> requires complete Th1 response <xref ref-type="bibr" rid="pone.0097992-Lewinsohn1">[27]</xref>. Some studies have reported that helminthic infections may facilitate the progression of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Borkow1">[28]</xref>, <xref ref-type="bibr" rid="pone.0097992-TristaoSa1">[29]</xref>.</p>
<p>This special immunological situation with the presence of helminths may also explain, in part, the QFT reversion phenomena. These reversion phenomena have, to date, been basically related to the clearance of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Pai5">[30]</xref>, the intermittent expression of the antigens of the RD1 region of <italic>Mtb</italic> during the latent phase <xref ref-type="bibr" rid="pone.0097992-Hill3">[31]</xref>, variability in laboratory procedures <xref ref-type="bibr" rid="pone.0097992-Veerapathran1">[32]</xref> and non-specific variations in IFN-γ levels when the test is repeated in the same individual <xref ref-type="bibr" rid="pone.0097992-Pai3">[21]</xref>.</p>
<p>On analyzing the discordant test results in the TST− group we observed that low ferritin levels were associated with QFT+ results. Likewise, we found that the TST− group presented lower exposure times (mean = 2.11, median = 1) than the TST+ individuals (mean = 7.32, median = 4). These two facts together, in addition to the fact that small children had probably not been previously exposed to <italic>Mtb,</italic> suggest that these individuals may be in an early phase of primary infection by <italic>Mtb</italic>. It has previously been reported that the antigens used in the Interferon-γ Release Assays ESAT-6 and CPF-10 are secreted mainly in early infection <xref ref-type="bibr" rid="pone.0097992-Hill1">[16]</xref>, <xref ref-type="bibr" rid="pone.0097992-Andersen1">[33]</xref>, <xref ref-type="bibr" rid="pone.0097992-Haile1">[34]</xref> and some studies in animals have related the initial response of primary infection to <italic>Mtb</italic> to a rapid rise in IFN-γ and a fall in ferritin values <xref ref-type="bibr" rid="pone.0097992-Thom1">[35]</xref> suggesting a true positivization of the QFT.</p>
<p>Iron (Fe) regulation requires a delicate balance between preventing an excess of Fe favoring survival, multiplication and virulence of <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Manabe1">[36]</xref> and providing sufficient Fe to ensure effective immune response <xref ref-type="bibr" rid="pone.0097992-Basaraba1">[37]</xref>. Mycobacteria competes for the sources of Fe with the host, thus, one strategy of immune response would be to decrease the availability of Fe to the mycobacteria <xref ref-type="bibr" rid="pone.0097992-Basaraba1">[37]</xref>, <xref ref-type="bibr" rid="pone.0097992-Ratledge1">[38]</xref>. Ferritin is a fundamental protein for the regulation of Fe, acting as a storage protein and managing the intracellular distribution of this element <xref ref-type="bibr" rid="pone.0097992-Harrison1">[39]</xref>. The clinical evolution of TB is reportedly worse in humans with both high and low ferritin levels <xref ref-type="bibr" rid="pone.0097992-Isanaka1">[40]</xref>.</p>
<p>The results of animal studies have indicated that a decrease in ferritin levels in primary infection is mainly mediated by IFN-γ <xref ref-type="bibr" rid="pone.0097992-Thom1">[35]</xref>. This phenomenon is not exclusive of subjects vaccinated with BCG but is more prolonged and more intense over time. Some authors have reported that strong regulation of Fe metabolism could explain, in part, the protector effect of the BCG vaccine against TB <xref ref-type="bibr" rid="pone.0097992-Thom1">[35]</xref>, <xref ref-type="bibr" rid="pone.0097992-Basaraba1">[37]</xref>.</p>
<p>Analysis of our data supports the contention that QFT probably undergoes more rapid conversion (step from negative to positive) after primary infection than the TST and would explain most of the discordant test results in this group as well as reinforce the importance of iron metabolism in the immune response against <italic>Mtb</italic> <xref ref-type="bibr" rid="pone.0097992-Reddy1">[41]</xref>. This is, to our knowledge, one of the first studies to explain this discordance related to time of exposure, ferritin levels and relating the metabolism of Fe with the initial immune response to primary infection in humans <xref ref-type="bibr" rid="pone.0097992-Banfield1">[26]</xref>, <xref ref-type="bibr" rid="pone.0097992-Friis1">[42]</xref>.</p>
</sec><sec id="s4c">
<title>Indeterminate QFT Results</title>
<p>The 14% of indeterminate results for QFT in this study suggests a limitation of the usefulness of IGRA in the pediatric TB setting. The proportion of indeterminate results varies greatly in studies in children <xref ref-type="bibr" rid="pone.0097992-Bergamini1">[43]</xref>–<xref ref-type="bibr" rid="pone.0097992-Haustein1">[45]</xref> and may be associated with technical problems and probably also factors which alter Th1 immune response <xref ref-type="bibr" rid="pone.0097992-Grare1">[46]</xref> such as age, the presence of helminths, and immunosuppression <xref ref-type="bibr" rid="pone.0097992-Thomas1">[25]</xref>. We found no association with any of the variables analyzed in this study or with the results of the TST, probably due to a lack of statistical power.</p>
</sec></sec><sec id="s5">
<title>Conclusions</title>
<p>The results of the present study strongly suggest the utility of the systematic study of household pediatric contacts for early detection of infection by <italic>Mtb</italic>.</p>
<p>Despite observing a lower concordance than expected, we observed that the main variable which may explain the results of the TST and QFT tests was the level of exposure to an index case. Likewise, the time of exposure was critical in the evaluation and reading of the test results.</p>
<p>On studying the discordant results between the tests we found that the presence of intestinal helminths and a short exposure time explained a large part of these results. For the interpretation of the discordant test results we recommend the study of intestinal helminthiasis (especially in settings of high prevalence) and estimation of the time of exposure and measurement of ferritin levels.</p>
<p>In the case of TST+&amp;QFT− results, the presence of intestinal helminths may produce false negative QFT results due to the negative impact of the helminths on Th1 immune response. In the case of TST−&amp;QFT+ results, low ferritin levels (&lt;37.5 ng/mL) and short time of exposure (&lt;2 months) could indicate initial stages of infection by <italic>Mtb</italic> with possible false negative TST results.</p>
<p>This study suggests the important role of iron metabolism in human immune response in primary infection by <italic>Mtb</italic> and the possibility that ferritin may be a biomarker in this phase <xref ref-type="bibr" rid="pone.0097992-Friis1">[42]</xref>, <xref ref-type="bibr" rid="pone.0097992-Jacobsen1">[47]</xref>.</p>
</sec></body>
<back>
<ack>
<p>The authors would like to thank the Policilinica Cardoso Fontes team and Fundação de Medicina Tropical Dr. Heitor Vieira Dourado for overall support.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0097992-World1"><label>1</label>
<mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2011) Global tuberculosis control 2011. Geneve: WHO. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/global_report/en/index.html" xlink:type="simple">http://www.who.int/tb/publications/global_report/en/index.html</ext-link>. Accessed 2012 July 22.</mixed-citation>
</ref>
<ref id="pone.0097992-Marais1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marais</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Gie</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Schaaf</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Hesseling</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Obihara</surname><given-names>CC</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era</article-title>. <source>Int J Tuberc Lung Dis</source> <volume>8</volume>: <fpage>392</fpage>–<lpage>402</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Starke1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Starke</surname><given-names>JR</given-names></name> (<year>2003</year>) <article-title>Pediatric tuberculosis: time for a new approach</article-title>. <source>Tuberculosis (Edinb)</source> <volume>83</volume>: <fpage>208</fpage>–<lpage>212</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Guidance1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children</collab> (<year>2006</year>) <article-title>Int J Tuberc Lung Dis</article-title>. <volume>10</volume>: <fpage>1091</fpage>–<lpage>1097</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Pai1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Riley</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Colford</surname><given-names>JM</given-names></name> (<year>2004</year>) <article-title>Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review</article-title>. <source>Lancet InfectDis</source> <volume>4</volume>: <fpage>761</fpage>–<lpage>776</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Comstock1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Comstock</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Livesay</surname><given-names>VT</given-names></name>, <name name-style="western"><surname>Woolpert</surname><given-names>SF</given-names></name> (<year>1974</year>) <article-title>The prognosis of a positive tuberculin reaction in childhood and adolescence</article-title>. <source>Am J Epidemiol</source> <volume>99</volume>: <fpage>131</fpage>–<lpage>138</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Farhat1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farhat</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Greenaway</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?</article-title> <source>Int J Tuberc Lung Dis</source> <volume>10</volume>: <fpage>1192</fpage>–<lpage>1204</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Pai2"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Riley</surname><given-names>LW</given-names></name>, <name name-style="western"><surname>Colford</surname><given-names>JM</given-names><suffix>Jr</suffix></name> (<year>2004</year>) <article-title>Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review</article-title>. <source>Lancet Infect Dis</source> <volume>4</volume>: <fpage>761</fpage>–<lpage>776</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(04)01206-X" xlink:type="simple">10.1016/S1473-3099(04)01206-X</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Machingaidze1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Machingaidze</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wiysonge</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Gonzalez-Angulo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hatherill</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moyo</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis</article-title>. <source>Pediatr Infect Dis J</source> <volume>30</volume>: <fpage>694</fpage>–<lpage>700</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/INF.0b013e318214b915" xlink:type="simple">10.1097/INF.0b013e318214b915</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Hesseling1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hesseling</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Mandalakas</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Kirchner</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Chegou</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Marais</surname><given-names>BJ</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Highly discordant T cell responses in individuals with recent exposure to household tuberculosis</article-title>. <source>Thorax</source> <volume>64</volume>: <fpage>840</fpage>–<lpage>846</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/thx.2007.085340" xlink:type="simple">10.1136/thx.2007.085340</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-World2"><label>11</label>
<mixed-citation publication-type="other" xlink:type="simple">World Health Organization. The WHO Child Growth Standards. WHO. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/childgrowth/standards/en/" xlink:type="simple">http://www.who.int/childgrowth/standards/en/</ext-link>. Accessed 2012 May 1.</mixed-citation>
</ref>
<ref id="pone.0097992-Lutz1"><label>12</label>
<mixed-citation publication-type="other" xlink:type="simple">Lutz A (1919) <italic>Schistosomum mansoni</italic> and Schistosomatosis observed in Brazil. Mem Inst Oswaldo Cruz: 121–155.</mixed-citation>
</ref>
<ref id="pone.0097992-Landis1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>GG</given-names></name> (<year>1977</year>) <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source> <volume>33</volume>: <fpage>159</fpage>–<lpage>174</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Powell1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Powell</surname><given-names>DA</given-names></name> (<year>2009</year>) <article-title>Interferon Gamma Release Assays in the Evaluation of Children With Possible <italic>Mycobacterium tuberculosis</italic> Infection: A View to Caution</article-title>. <source>Pediatr Infect Dis J</source> <volume>28</volume>: <fpage>676</fpage>–<lpage>677</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Dheda1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dheda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>van Zyl Smit</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Badri</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings</article-title>. <source>Curr Opin Pulm Med</source> <volume>15</volume>: <fpage>188</fpage>–<lpage>200</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MCP.0b013e32832a0adc" xlink:type="simple">10.1097/MCP.0b013e32832a0adc</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Hill1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Brookes</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Adetifa</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jackson-Sillah</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Pediatrics</source> <volume>117</volume>: <fpage>1542</fpage>–<lpage>1548</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Almeida1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Almeida</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Barbieri</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Da Paixão</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Cuevas</surname><given-names>LE</given-names></name> (<year>2001</year>) <article-title>Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage</article-title>. <source>Pediatr Infect Dis J</source> <volume>20</volume>: <fpage>1061</fpage>–<lpage>1065</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Raharimanga1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raharimanga</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Ratovoson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ratsitorahina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ramarokoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rasolofo</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Tuberculin reactivity in first-year schoolchildren in Madagascar</article-title>. <source>Trop Med Int Health</source> <volume>17</volume>: <fpage>871</fpage>–<lpage>876</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-3156.2012.03013.x" xlink:type="simple">10.1111/j.1365-3156.2012.03013.x</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Hill2"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Ota</surname><given-names>MOC</given-names></name> (<year>2010</year>) <article-title>Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases</article-title>. <source>Lancet Infect Dis</source> <volume>10</volume>: <fpage>723</fpage>–<lpage>732</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(10)70164-X" xlink:type="simple">10.1016/S1473-3099(10)70164-X</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Shanaube1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shanaube</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hargreaves</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fielding</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Schaap</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>K-A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa</article-title>. <source>PLoS ONE</source> <volume>6</volume>: <fpage>e18206</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0018206" xlink:type="simple">10.1371/journal.pone.0018206</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Pai3"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dogra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zwerling</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Gajalakshmi</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India</article-title>. <source>Int J Tuberc Lung Dis</source> <volume>13</volume>: <fpage>84</fpage>–<lpage>92</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Resende1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Resende</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Hirsch</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Toossi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dietze</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ribeiro-Rodrigues</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>Intestinal helminth co-infection has a negative impact on both anti-<italic>Mycobacterium tuberculosis</italic> immunity and clinical response to tuberculosis therapy</article-title>. <source>Clin Exp Immunol</source> <volume>147</volume>: <fpage>45</fpage>–<lpage>52</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Pai4"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kalantri</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>Discordance between tuberculin skin test and interferon-gamma assays</article-title>. <source>Int J Tuberc Lung Dis</source> <volume>10</volume>: <fpage>942</fpage>–<lpage>943</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Mandalakas1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mandalakas</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Detjen</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Hesseling</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Benedetti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Menzies</surname><given-names>D</given-names></name> (<year>2011</year>) <article-title>Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis</article-title>. <source>Int J Tuberc Lung Dis</source> <volume>15</volume>: <fpage>1018</fpage>–<lpage>1032</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5588/ijtld.10.0631" xlink:type="simple">10.5588/ijtld.10.0631</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Thomas1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Mondal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Noor</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Alam</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Malnutrition and helminth infection affect performance of an interferon gamma-release assay</article-title>. <source>Pediatrics</source> <volume>126</volume>: <fpage>e1522</fpage>–<lpage>1529</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2010-0885" xlink:type="simple">10.1542/peds.2010-0885</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Banfield1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Banfield</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pascoe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thambiran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siafarikas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Burgner</surname><given-names>D</given-names></name> (<year>2012</year>) <article-title>Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis</article-title>. <source>PLoS ONE</source> <volume>7</volume>: <fpage>e38556</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0038556" xlink:type="simple">10.1371/journal.pone.0038556</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Lewinsohn1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewinsohn</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Lewinsohn</surname><given-names>DM</given-names></name> (<year>2008</year>) <article-title>Immunologic susceptibility of young children to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PediatrRes</source> <volume>63</volume>: <fpage>115</fpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Borkow1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borkow</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Leng</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Weisman</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Stein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Galai</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy</article-title>. <source>J Clin Invest</source> <volume>106</volume>: <fpage>1053</fpage>–<lpage>1060</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI10182" xlink:type="simple">10.1172/JCI10182</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-TristaoSa1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tristao-Sa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ribeiro-Rodrigues</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Dietze</surname><given-names>R</given-names></name> (<year>2002</year>) <article-title>Intestinal nematodes and pulmonary tuberculosis</article-title>. <source>Rev Soc Bras Med Trop</source> <volume>35</volume>: <fpage>533</fpage>–<lpage>535</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Pai5"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>O’Brien</surname><given-names>R</given-names></name> (<year>2007</year>) <article-title>Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?</article-title> <source>PLoS Med</source> <volume>4</volume>: <fpage>e208</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0040208" xlink:type="simple">10.1371/journal.pmed.0040208</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Hill3"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Brookes</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jackson-Sillah</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Longitudinal assessment of an ELISPOT test for <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>PLoS Med</source> <volume>4</volume>: <fpage>e192</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0040192" xlink:type="simple">10.1371/journal.pmed.0040192</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Veerapathran1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Veerapathran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Goswami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dogra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moodie</surname><given-names>EEM</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data</article-title>. <source>PLoS ONE</source> <volume>3</volume>: <fpage>e1850</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0001850" xlink:type="simple">10.1371/journal.pone.0001850</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Andersen1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andersen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Askgaard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ljungqvist</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bennedsen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Heron</surname><given-names>I</given-names></name> (<year>1991</year>) <article-title>Proteins released from <italic>Mycobacterium tuberculosis</italic> during growth</article-title>. <source>Infect Immun</source> <volume>59</volume>: <fpage>1905</fpage>–<lpage>1910</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Haile1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haile</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bjune</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wiker</surname><given-names>HG</given-names></name> (<year>2002</year>) <article-title>Expression of the mceA, esat-6 and hspX genes in <italic>Mycobacterium tuberculosis</italic> and their responses to aerobic conditions and to restricted oxygen supply</article-title>. <source>Microbiology (Reading, Engl)</source> <volume>148</volume>: <fpage>3881</fpage>–<lpage>3886</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Thom1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thom</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Elmore</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Drobniewski</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and <italic>Mycobacterium tuberculosis</italic> challenge</article-title>. <source>Vaccine</source> <volume>30</volume>: <fpage>3159</fpage>–<lpage>3168</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vaccine.2012.03.008" xlink:type="simple">10.1016/j.vaccine.2012.03.008</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Manabe1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manabe</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Saviola</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bishai</surname><given-names>WR</given-names></name> (<year>1999</year>) <article-title>Attenuation of virulence in <italic>Mycobacterium tuberculosis</italic> expressing a constitutively active iron repressor</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>96</volume>: <fpage>12844</fpage>–<lpage>12848</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Basaraba1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Basaraba</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Bielefeldt-Ohmann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eschelbach</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Reisenhauer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tolnay</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig</article-title>. <source>Tuberculosis (Edinb)</source> <volume>88</volume>: <fpage>69</fpage>–<lpage>79</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tube.2007.09.002" xlink:type="simple">10.1016/j.tube.2007.09.002</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Ratledge1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ratledge</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Iron, mycobacteria and tuberculosis</article-title>. <source>Tuberculosis(Edinb)</source> <volume>84</volume>: <fpage>110</fpage>–<lpage>130</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Harrison1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harrison</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Arosio</surname><given-names>P</given-names></name> (<year>1996</year>) <article-title>The ferritins: molecular properties, iron storage function and cellular regulation</article-title>. <source>Biochim Biophys Acta</source> <volume>1275</volume>: <fpage>161</fpage>–<lpage>203</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Isanaka1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Isanaka</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aboud</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mugusi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bosch</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Willett</surname><given-names>WC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania</article-title>. <source>PLoS ONE</source> <volume>7</volume>: <fpage>e37350</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0037350" xlink:type="simple">10.1371/journal.pone.0037350</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Reddy1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reddy</surname><given-names>PV</given-names></name>, <name name-style="western"><surname>Puri</surname><given-names>RV</given-names></name>, <name name-style="western"><surname>Khera</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tyagi</surname><given-names>AK</given-names></name> (<year>2012</year>) <article-title>Iron storage proteins are essential for the survival and pathogenesis of <italic>Mycobacterium tuberculosis</italic> in THP-1 macrophages and the guinea pig model of infection</article-title>. <source>J Bacteriol</source> <volume>194</volume>: <fpage>567</fpage>–<lpage>575</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.05553-11" xlink:type="simple">10.1128/JB.05553-11</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Friis1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friis</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Range</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Braendgaard</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Kaestel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Changalucha</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania</article-title>. <source>BrJNutr</source> <volume>102</volume>: <fpage>310</fpage>–<lpage>317</lpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Bergamini1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bergamini</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Losi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vaienti</surname><given-names>F</given-names></name>, <name name-style="western"><surname>D’Amico</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Meccugni</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents</article-title>. <source>Pediatrics</source> <volume>123</volume>: <fpage>e419</fpage>–<lpage>424</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2008-1722" xlink:type="simple">10.1542/peds.2008-1722</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Connell1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Connell</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Ritz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Paxton</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Buttery</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Curtis</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children</article-title>. <source>PLoSONE</source> <volume>3</volume>: <fpage>e2624</fpage>.</mixed-citation>
</ref>
<ref id="pone.0097992-Haustein1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haustein</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ridout</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Hartley</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Thaker</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Shingadia</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of <italic>Mycobacterium tuberculosis</italic> infection in children correlates with age and immune status</article-title>. <source>Pediatr Infect Dis J</source> <volume>28</volume>: <fpage>669</fpage>–<lpage>673</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/INF.0b013e3181a16394" xlink:type="simple">10.1097/INF.0b013e3181a16394</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Grare1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grare</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Derelle</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dailloux</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Laurain</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>QuantiFERON-TB Gold In-Tube as help for the diagnosis of tuberculosis in a French pediatric hospital</article-title>. <source>Diagn Microbiol Infect Dis</source> <volume>66</volume>: <fpage>366</fpage>–<lpage>372</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.diagmicrobio.2009.11.002" xlink:type="simple">10.1016/j.diagmicrobio.2009.11.002</ext-link></comment></mixed-citation>
</ref>
<ref id="pone.0097992-Jacobsen1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jacobsen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Repsilber</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gutschmidt</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Neher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Feldmann</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Candidate biomarkers for discrimination between infection and disease caused by <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Mol Med</source> <volume>85</volume>: <fpage>613</fpage>–<lpage>621</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00109-007-0157-6" xlink:type="simple">10.1007/s00109-007-0157-6</ext-link></comment></mixed-citation>
</ref>
</ref-list></back>
</article>